midazolam has been researched along with gyki 52466 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
AndrĂ¡si, F; Berzsenyi, P; Farkas, S; Pataki, A; Tarnawa, I | 1 |
Boehrer, A; Depaulis, A; Heinrich, C; Kurokawa, K; Matsuda, M; Mitsuya, K; Suzuki, F | 1 |
2 other study(ies) available for midazolam and gyki 52466
Article | Year |
---|---|
Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Cats; Electrophysiology; Evoked Potentials; Male; Midazolam; Muscle Relaxants, Central; Purkinje Cells; Receptors, GABA-A; Reflex, Monosynaptic; Spinal Cord | 1989 |
Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy.
Topics: Animals; Benzodiazepines; Cell Count; Dentate Gyrus; Disease Models, Animal; Dizocilpine Maleate; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; GABA Modulators; Hippocampus; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Midazolam; Mossy Fibers, Hippocampal; Neurons; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2005 |